Literature DB >> 1815546

Idiopathic inflammatory pseudotumour of the orbit: CT features correlated with clinical outcome.

M M McNicholas1, W J Power, J F Griffin.   

Abstract

Idiopathic orbital pseudotumour is an inflammatory condition which usually presents as an orbital mass. The response to treatment is variable and often unpredictable. In this study we have assessed the spectrum of computed tomographic (CT) appearances in 17 patients. Four categories of orbital pseudotumour were identified by CT based on the location and extent of the inflammatory process within the orbit. Patients within each of the four categories had broadly similar clinical outcomes. CT was valuable in identifying certain prognostic features enabling better clinical and therapeutic planning.

Entities:  

Mesh:

Year:  1991        PMID: 1815546     DOI: 10.1016/s0009-9260(05)80216-8

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

1.  MRI of idiopathic orbital inflammatory syndrome using fat saturation and Gd-DTPA.

Authors:  J A Hardman; S F Halpin; S Mars; M D Hourihan; C M Lane
Journal:  Neuroradiology       Date:  1995-08       Impact factor: 2.804

Review 2.  Orbital myositis: diagnosis and management.

Authors:  Roberta M S Costa; Oana M Dumitrascu; Lynn K Gordon
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

Review 3.  [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].

Authors:  S E Coupland
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

4.  Atypical presentation of orbital pseudotumor with visual loss as an initial manifestation.

Authors:  Recai Turkoglu; Naci Balak
Journal:  J Clin Neurol       Date:  2011-03-31       Impact factor: 3.077

5.  Idiopathic sclerosing orbital pseudotumor in seven cats.

Authors:  F Mark Billson; Tammy Miller-Michau; John R B Mould; Michael G Davidson
Journal:  Vet Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 1.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.